EG22337A - Process for preparing novel pharmaceutical compounds - Google Patents

Process for preparing novel pharmaceutical compounds

Info

Publication number
EG22337A
EG22337A EG155698A EG155698A EG22337A EG 22337 A EG22337 A EG 22337A EG 155698 A EG155698 A EG 155698A EG 155698 A EG155698 A EG 155698A EG 22337 A EG22337 A EG 22337A
Authority
EG
Egypt
Prior art keywords
pharmaceutical compounds
novel pharmaceutical
preparing novel
preparing
compounds
Prior art date
Application number
EG155698A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of EG22337A publication Critical patent/EG22337A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EG155698A 1997-12-16 1998-12-15 Process for preparing novel pharmaceutical compounds EG22337A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726566.4A GB9726566D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
EG22337A true EG22337A (en) 2002-12-31

Family

ID=10823692

Family Applications (1)

Application Number Title Priority Date Filing Date
EG155698A EG22337A (en) 1997-12-16 1998-12-15 Process for preparing novel pharmaceutical compounds

Country Status (35)

Country Link
EP (2) EP1040110A1 (fr)
JP (1) JP2002508373A (fr)
KR (1) KR100549142B1 (fr)
CN (3) CN1281453A (fr)
AP (1) AP1365A (fr)
AR (1) AR017214A1 (fr)
AU (1) AU1967999A (fr)
BG (1) BG64988B1 (fr)
BR (1) BR9813600A (fr)
CA (1) CA2314107A1 (fr)
CO (1) CO4980880A1 (fr)
CZ (1) CZ299965B6 (fr)
DZ (1) DZ2681A1 (fr)
EA (1) EA004260B1 (fr)
EG (1) EG22337A (fr)
GB (1) GB9726566D0 (fr)
HR (1) HRP20000408B1 (fr)
HU (1) HUP0100509A3 (fr)
IL (1) IL136424A (fr)
IN (1) IN192487B (fr)
MA (1) MA26580A1 (fr)
MY (1) MY135612A (fr)
NO (1) NO317254B1 (fr)
OA (1) OA11766A (fr)
PE (1) PE20000058A1 (fr)
PL (1) PL341146A1 (fr)
RS (1) RS50126B (fr)
SA (1) SA99191115B1 (fr)
SK (1) SK286618B6 (fr)
TR (2) TR200001799T2 (fr)
TW (1) TW509690B (fr)
UA (1) UA72198C2 (fr)
UY (2) UY25308A1 (fr)
WO (1) WO1999031095A1 (fr)
ZA (1) ZA9811506B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
NZ515167A (en) * 1999-04-23 2004-02-27 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic
US6806280B1 (en) * 1999-04-23 2004-10-19 Smithkline Beecham P.L.C. Polymorph of 5-[4-[2-(n-methyl-n(2-pyridyl)amino)ethoxy]benzyl]-thiazolidine-2,4-dione, maleic acid salt
KR100744359B1 (ko) 1999-04-23 2007-07-30 스미스클라인비이참피이엘시이 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
US6770133B2 (en) 2000-04-25 2004-08-03 Kyorin Pharmaceutical Co., Ltd. Stable crystal of thiazolidinedione derivative and process for producing the same
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
HUP0301161A3 (en) * 2000-09-26 2005-04-28 Reddy S Res Foundation Hyderab Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleate and process for their preparation
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2003050112A1 (fr) * 2001-12-13 2003-06-19 Smithkline Beecham Plc Hydrates de toluenesulfonate d'un derive de thiazolidinedione
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP2184055A1 (fr) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Procédé de préparation de formes galéniques solides de maléate de rosiglitazone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
JPH09512249A (ja) * 1994-02-10 1997-12-09 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 腎臓疾患を治療するためのインスリンセンシタイザーの使用

Also Published As

Publication number Publication date
EP1661895A1 (fr) 2006-05-31
EA200000654A1 (ru) 2000-12-25
TR199802625A2 (xx) 1999-10-21
PL341146A1 (en) 2001-03-26
UA72198C2 (en) 2005-02-15
MA26580A1 (fr) 2004-12-20
KR20010033141A (ko) 2001-04-25
KR100549142B1 (ko) 2006-02-03
UY25304A1 (es) 2000-12-29
OA11766A (en) 2005-07-19
BG64988B1 (bg) 2006-11-30
HRP20000408B1 (en) 2008-04-30
CO4980880A1 (es) 2000-11-27
AP1365A (en) 2005-01-26
IL136424A0 (en) 2001-06-14
AP2000001831A0 (en) 2000-06-30
JP2002508373A (ja) 2002-03-19
SK9172000A3 (en) 2001-01-18
NO20003069L (no) 2000-06-15
CZ299965B6 (cs) 2009-01-07
EP1040110A1 (fr) 2000-10-04
UY25308A1 (es) 1999-07-19
WO1999031095A1 (fr) 1999-06-24
GB9726566D0 (en) 1998-02-11
MY135612A (en) 2008-05-30
SK286618B6 (sk) 2009-02-05
SA99191115B1 (ar) 2006-10-11
TR200001799T2 (tr) 2001-01-22
DZ2681A1 (fr) 2004-06-20
NO317254B1 (no) 2004-09-27
BR9813600A (pt) 2000-10-10
AR017214A1 (es) 2001-08-22
RS50126B (sr) 2009-03-25
IN192487B (fr) 2004-04-24
PE20000058A1 (es) 2000-02-26
CN101302215A (zh) 2008-11-12
HUP0100509A3 (en) 2002-06-28
NO20003069D0 (no) 2000-06-15
TR199802625A3 (tr) 1999-10-21
HRP20000408A2 (en) 2000-08-31
BG104603A (en) 2001-03-30
CA2314107A1 (fr) 1999-06-24
EA004260B1 (ru) 2004-02-26
CN101381367A (zh) 2009-03-11
CN1281453A (zh) 2001-01-24
IL136424A (en) 2003-12-10
YU36300A (sh) 2004-03-12
AU1967999A (en) 1999-07-05
TW509690B (en) 2002-11-11
HUP0100509A2 (hu) 2002-05-29
ZA9811506B (en) 2000-11-06
CZ20002204A3 (cs) 2000-11-15

Similar Documents

Publication Publication Date Title
EG22337A (en) Process for preparing novel pharmaceutical compounds
CY2551B1 (en) Process for preparing eprosartan
CY2555B1 (en) Process for preparing eprosartan
HU9802180D0 (en) Process for producing pharmaceutical compositions
EP1026255A4 (fr) Procede de preparation de xylitol
EP0908524A4 (fr) Procede de production d'une substance riche en alpha-monoglucosylhesperidine
SG70092A1 (en) Process for preparing dialkylnaphthalene
IL133140A0 (en) Novel process for the preparation of 4-aryl-piperidines
IL134059A0 (en) Process for preparing aminoarylacetylenes
IL131205A0 (en) Process for preparing pharmaceutical compounds
EG22077A (en) Process for preparing 4-substituted-ih-indole-3 glyoxamides
EP1026254A4 (fr) Procede de preparation de xylitol
EP0688770A3 (fr) Procédé pour la préparation de composés hydroxyflavans
EP0932601A4 (fr) Procede de preparation de composes pharmaceutiques
IL126184A0 (en) Process for preparing pentafluoropentanol
EG21226A (en) Process for preparing of new pharmaceutical compound
IL133288A (en) Process for preparing 3-isochromanone
GB9810502D0 (en) Process for preparing distrylbiphenyl compounds
EP0694512A3 (fr) Procédé pour la préparation des composés C4-alkyle hexofluoré
HU9701137D0 (en) Process for producing pharmaceutical intermedier
IL125646A (en) Process for preparing N-pyruvyl-L-proline
GB9800066D0 (en) Process for preparing dibenzocycycloheptene compounds
AU7667598A (en) Process for preparing 3-isochromanome
AU8232098A (en) Process for preparing tri-aryl-alkylalkenes
IL128643A0 (en) Process to prepare pharmaceutical compounds